<DOC>
	<DOC>NCT00559260</DOC>
	<brief_summary>This is a 300 subject prospective study to assess cardiorespiratory events associated with current practice sedation (150 subjects; opioid + benzodiazepine) versus anesthesia provider sedation (150 subjects; propofol) for upper and/or lower endoscopy.</brief_summary>
	<brief_title>Evaluation of Cardiorespiratory Events in Subjects Undergoing an Upper and/or Lower Endoscopy Under Current Sedation Practices</brief_title>
	<detailed_description />
	<criteria>adult (&gt;=18 years),ASA IIII, nonemergent upper and/or lower endoscopy Emergent indications for upper and/or lower endoscopy (i.e., acute hemorrhage, cholangitis) Baseline respiratory rate of &lt; 6 breaths per minute Baseline hypotension (systolic blood pressure &lt; 90 mm Hg) Baseline arterial oxygen saturation &lt; 90% on room air Baseline bradycardia: heart rate &lt; 50 beats per minute Baseline tachycardia: heart rate &gt; 110 beats per minute Allergy or inability to tolerate any of the sedatives or analgesics to be administered during the procedure Inability to squeeze the Automated Responsiveness Test hand piece (last 50 subjects only) Significant hearing impairment Actively abusing alcohol, opioids, benzodiazapines or sedatives, or other drugs Are considered tolerant to opioids, benzodiazapines and/or other sedatives through prescription.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
</DOC>